COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,051 Articles (22,627 medRxiv, 8,424 bioRxiv)

Most recent first Previous |  Page 1609: Articles 16081-16090  | Next

Nanobody Repertoires for Exposing Vulnerabilities of SARS-CoV-2
Mast, F. D., Fridy, P. C., Ketaren, N. E., Wang, J., Jacobs, E. Y., Olivier, J. P., Sanyal, T., Molloy, K. R., Schmidt, F., Rutkowska, M., Weisblum, Y., Rich, L. M., Vanderwall, E. R., Dambrauskas, N., Vigdorovich, V., Keegan, S., Jiler, J. B., Stein, M. E., Olinares, P. D. B., Hatziioannou, T., Sather, D. N., Debley, J. S., Fenyö, D., Sali, A., Bieniasz, P. D., Aitchison, J. D., Chait, B. T., Rout, M. P.
10.1101/2021.04.08.438911 — Posted: 2021-04-10
A trimeric hydrophobic zipper mediates the intramembrane assembly of SARS-CoV-2 spike
Fu, Q., Chou, J. J.
10.1101/2021.04.09.439203 — Posted: 2021-04-10
The homology analysis of ACE2 gene and its distinct expression in laboratory and wild animals
Wang, G., A-Mei, Z., Binghui, W., Yin, J., Yue, F., Baloch, Z., Xia, X.-s.
10.1101/2021.04.08.439088 — Posted: 2021-04-10
Theoretical causes of the Brazilian P.1 and P.2 lineages of the SARS-CoV-2 virus through molecular dynamics
Lima de Oliveira, M. D., Teixeira de Oliveira, K. M., Nunes da Silva, J., Santos, C., Bessa, J., de Freitas Rodrigues, R.
10.1101/2021.04.09.439181 — Posted: 2021-04-10
Exploring zebrafish larvae as a COVID-19 model: probable SARS-COV-2 replication in the swim bladder
Laghi, V., Rezelj, V., Boucontet, L., Boudinot, P., Salinas, I., Lutfalla, G., Vignuzzi, M., Levraud, J.-P.
10.1101/2021.04.08.439059 — Posted: 2021-04-10
Reflections of COVID-19 cases on the wastewater loading of SARS-CoV-2 RNA: A case of three major cities of Gujarat, India
Srivastava, V., Gupta, S., Patel, A., Joshi, M., Kumar, M.
10.1101/2021.04.08.21254861 — Posted: 2021-04-10
Cardiac Surgery during the Covid-19 Pandemic: Evidence from the first wave
Vandoros, S., Schizas, N., Apostolopoulos, A., Patris, V., Argiriou, M.
10.1101/2021.04.07.21254206 — Posted: 2021-04-10
Antibody Responses in Elderly Residential Care Persons following COVID-19 mRNA Vaccination
Nace, D. A., Kip, K. E., Peck Palmer, O. M., Shurin, M. R., Mulvey, K., Crandall, M., Kane, A. L., Lukanski, A., Kip, P. L., Wells, A. L.
10.1101/2021.04.07.21254925 — Posted: 2021-04-10
Covid-19 and Excess Mortality in Medicare Beneficiaries
Greenwald, S. D., Chamoun, N. G., Manberg, P. J., Gray, J., Clain, D., Maheshwari, K., Sessler, D. I.
10.1101/2021.04.07.21254793 — Posted: 2021-04-10
Nasal delivery of single-domain antibodies improve symptoms of SARS-CoV-2 infection in an animal model
Haga, K., Takai-Todaka, R., Matsumura, Y., Takano, T., Tojo, T., Nagami, A., Ishida, Y., Masaki, H., Tsuchiya, M., Ebisudani, T., Sugimoto, S., Sato, T., Yasuda, H., Fukunaga, K., Sawada, A., Nemoto, N., Song, C., Murata, K., Morimoto, T., Katayama, K.
10.1101/2021.04.09.439147 — Posted: 2021-04-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).